Document Detail


Increased regional cerebral glucose uptake in an APP/PS1 model of Alzheimer's disease.
MedLine Citation:
PMID:  22079157     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Alzheimer's disease (AD), the most common age-related neurodegenerative disorder, is characterized by the invariant cerebral accumulation of β-amyloid peptide. This event occurs early in the disease process. In humans, [18F]-fluoro-2-deoxy-D-glucose ([18F]-FDG) positron emission tomography (PET) is largely used to follow-up in vivo cerebral glucose utilization (CGU) and brain metabolism modifications associated with the Alzheimer's disease pathology. Here, [18F]-FDG positron emission tomography was used to study age-related changes of cerebral glucose utilization under resting conditions in 3-, 6-, and 12-month-old APP(SweLon)/PS1(M146L), a mouse model of amyloidosis. We showed an age-dependent increase of glucose uptake in several brain regions of APP/PS1 mice but not in control animals and a higher [18F]-FDG uptake in the cortex and the hippocampus of 12-month-old APP/PS1 mice as compared with age-matched control mice. We then developed a method of 3-D microscopic autoradiography to evaluate glucose uptake at the level of amyloid plaques and showed an increased glucose uptake close to the plaques rather than in amyloid-free cerebral tissues. These data suggest a macroscopic and microscopic reorganization of glucose uptake in relation to cerebral amyloidosis.
Authors:
Géraldine Poisnel; Anne-Sophie Hérard; Nadine El Tannir El Tayara; Emmanuel Bourrin; Andreas Volk; Frank Kober; Benoit Delatour; Thierry Delzescaux; Thomas Debeir; Thomas Rooney; Jésus Benavides; Philippe Hantraye; Marc Dhenain
Related Documents :
18569877 - Secretory expression of insulin precursor in pichia pastoris and simple procedure for p...
21749267 - Targeting amyloid-beta by glucagon-like peptide -1 (glp-1) in alzheimer's disease and d...
8181257 - Improved beta cell function, with reduction in secretion of intact and 32/33 split proi...
21188517 - Neurochemical correlates of alloxan diabetes: glucose and related brain metabolism in t...
12408407 - Long-term consequences of type 2 diabetes mellitus: economic impact on society and mana...
12105247 - Early referral of type 2 diabetic patients: are we ready for the assault?
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-11-11
Journal Detail:
Title:  Neurobiology of aging     Volume:  -     ISSN:  1558-1497     ISO Abbreviation:  -     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-11-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8100437     Medline TA:  Neurobiol Aging     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Inc. All rights reserved.
Affiliation:
Therapeutic Strategic Unit Aging, Alzheimer/Parkinson/Stroke, Chilly-Mazarin, France; CEA, I2BM, MIRCen, Fontenay aux Roses, France; CNRS, URA 2210, Fontenay aux Roses, France; Servier Research Institute, Division of Neurodegenerative Diseases, Croissy-sur-Seine, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Microthrombosis after experimental subarachnoid hemorrhage: Time course and effect of red blood cell...
Next Document:  Does frequency matter? ERP and behavioral correlates of monitoring for rare and frequent prospective...